Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57)

A Wright, ACF Burden, RB Paisey, CA Cull… - Diabetes …, 2002 - Am Diabetes Assoc
OBJECTIVE—To evaluate the efficacy of the addition of insulin when maximal sulfonylurea
therapy is inadequate in individuals with type 2 diabetes. RESEARCH DESIGN AND …

New Alström syndrome phenotypes based on the evaluation of 182 cases

JD Marshall, RT Bronson, GB Collin… - Archives of internal …, 2005 - jamanetwork.com
Background Alström syndrome is a recessively inherited genetic disorder characterized by
congenital retinal dystrophy that leads to blindness, hearing impairment, childhood obesity …

Short‐term effects of severe dietary carbohydrate‐restriction advice in Type 2 diabetes—a randomized controlled trial

ME Daly, R Paisey, R Paisey, BA Millward… - Diabetic …, 2006 - Wiley Online Library
Objective This study sought to examine the effects of a 3‐month programme of dietary
advice to restrict carbohydrate intake compared with reduced‐portion, low‐fat advice in …

Alström syndrome

R Paisey, R Steeds, T Barrett, D Williams… - … : a reference for …, 2013 - books.google.com
Carl Henry Alström was born in Vasteras in Sweden in 1907 and was 52 years old when he
published case studies made over 13 years of first one case and then two second cousins …

[HTML][HTML] Consensus clinical management guidelines for Alström syndrome

N Tahani, P Maffei, H Dollfus, R Paisey… - Orphanet journal of rare …, 2020 - Springer
Alström Syndrome (ALMS) is an ultra-rare multisystem genetic disorder caused by
autosomal recessive variants in the ALMS1 gene, which is located on chromosome 2p13 …

Monogenic diabetes syndromes: Locus‐specific databases for Alström, Wolfram, and Thiamine‐responsive megaloblastic anemia

D Astuti, A Sabir, P Fulton, M Zatyka… - Human …, 2017 - Wiley Online Library
We developed a variant database for diabetes syndrome genes, using the Leiden Open
Variation Database platform, containing observed phenotypes matched to the genetic …

G lucagon‐like peptide‐1 analogues in monogenic syndromic obesity: Real‐world data from a large cohort of Alström syndrome patients

S Ali, S Baig, S Wanninayake… - Diabetes, Obesity …, 2024 - Wiley Online Library
Aim To examine the real‐world efficacy of glucagon‐like peptide‐1 receptor agonists (GLP‐
1 RAs) in monogenic obesity in patients with Alström syndrome (ALMS). Methods We …

Defining renal phenotype in Alström syndrome

S Baig, R Paisey, C Dawson, T Barrett… - Nephrology Dialysis …, 2020 - academic.oup.com
Background Alström syndrome (AS) is a rare autosomal recessive ciliopathy with a wide
spectrum of clinical features, including cone–rod retinal dystrophy, neuronal deafness …

The progression from obesity to type 2 diabetes in Alström syndrome

V Bettini, P Maffei, C Pagano, S Romano… - Pediatric …, 2012 - Wiley Online Library
Bettini V, Maffei P, Pagano C, Romano S, Milan G, Favaretto F, Marshall JD, Paisey R,
Scolari F, Greggio NA, Tosetto I, Naggert JK, Sicolo N, Vettor R. The progression from …

[HTML][HTML] Clinical utility gene card for: Alström Syndrome-update 2013

JD Marshall, P Maffei, S Beck, TG Barrett… - European Journal of …, 2013 - nature.com
1.5 Mutational spectrum There have been 106 different disease-causing mutations
described thus far, including nonsense (55%), indels (42%), and rare compound frameshift …